nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—Cladribine—Floxuridine—stomach cancer	0.419	1	CrCrCtD
Fludarabine—SLC29A1—Fluorouracil—stomach cancer	0.262	1	CbGbCtD
Fludarabine—SLC28A3—pancreas—stomach cancer	0.00294	0.067	CbGeAlD
Fludarabine—POLA1—hematopoietic system—stomach cancer	0.00254	0.0578	CbGeAlD
Fludarabine—SLC28A3—digestive system—stomach cancer	0.00251	0.0572	CbGeAlD
Fludarabine—SLC28A3—bone marrow—stomach cancer	0.00232	0.0527	CbGeAlD
Fludarabine—DCK—Topotecan—Irinotecan—stomach cancer	0.0022	0.688	CbGdCrCtD
Fludarabine—RRM1—hematopoietic system—stomach cancer	0.00201	0.0459	CbGeAlD
Fludarabine—Flavin adenine dinucleotide—ACAD8—stomach cancer	0.00185	0.273	CrCbGaD
Fludarabine—RRM1—smooth muscle tissue—stomach cancer	0.00177	0.0404	CbGeAlD
Fludarabine—RRM1—pancreas—stomach cancer	0.00164	0.0373	CbGeAlD
Fludarabine—SLC29A1—hematopoietic system—stomach cancer	0.00164	0.0373	CbGeAlD
Fludarabine—POLA1—bone marrow—stomach cancer	0.00163	0.037	CbGeAlD
Fludarabine—DCK—hematopoietic system—stomach cancer	0.00157	0.0356	CbGeAlD
Fludarabine—RRM1—lymphoid tissue—stomach cancer	0.00142	0.0323	CbGeAlD
Fludarabine—RRM1—digestive system—stomach cancer	0.0014	0.0319	CbGeAlD
Fludarabine—SLC29A1—pancreas—stomach cancer	0.00133	0.0304	CbGeAlD
Fludarabine—POLA1—liver—stomach cancer	0.00132	0.0299	CbGeAlD
Fludarabine—RRM1—bone marrow—stomach cancer	0.00129	0.0294	CbGeAlD
Fludarabine—DCK—pancreas—stomach cancer	0.00127	0.029	CbGeAlD
Fludarabine—RRM1—endocrine gland—stomach cancer	0.00116	0.0264	CbGeAlD
Fludarabine—SLC29A1—lymphoid tissue—stomach cancer	0.00115	0.0263	CbGeAlD
Fludarabine—SLC29A1—digestive system—stomach cancer	0.00114	0.0259	CbGeAlD
Fludarabine—DCK—lymphoid tissue—stomach cancer	0.0011	0.0251	CbGeAlD
Fludarabine—DCK—digestive system—stomach cancer	0.00109	0.0248	CbGeAlD
Fludarabine—SLC29A1—bone marrow—stomach cancer	0.00105	0.0239	CbGeAlD
Fludarabine—RRM1—liver—stomach cancer	0.00104	0.0238	CbGeAlD
Fludarabine—POLA1—lymph node—stomach cancer	0.00101	0.023	CbGeAlD
Fludarabine—DCK—bone marrow—stomach cancer	0.001	0.0228	CbGeAlD
Fludarabine—Adenosine monophosphate—FBP1—stomach cancer	0.000968	0.143	CrCbGaD
Fludarabine—Adenosine monophosphate—PRKAB1—stomach cancer	0.000968	0.143	CrCbGaD
Fludarabine—SLC29A1—endocrine gland—stomach cancer	0.000941	0.0214	CbGeAlD
Fludarabine—DCK—endocrine gland—stomach cancer	0.000899	0.0205	CbGeAlD
Fludarabine—SLC29A1—liver—stomach cancer	0.000849	0.0193	CbGeAlD
Fludarabine—Cytarabine—NT5E—stomach cancer	0.000813	0.12	CrCbGaD
Fludarabine—DCK—liver—stomach cancer	0.000811	0.0185	CbGeAlD
Fludarabine—RRM1—lymph node—stomach cancer	0.0008	0.0182	CbGeAlD
Fludarabine—Azacitidine—DNMT1—stomach cancer	0.000654	0.0967	CrCbGaD
Fludarabine—SLC29A1—lymph node—stomach cancer	0.000651	0.0148	CbGeAlD
Fludarabine—DCK—lymph node—stomach cancer	0.000622	0.0142	CbGeAlD
Fludarabine—Adenosine monophosphate—PRKAA1—stomach cancer	0.000556	0.0822	CrCbGaD
Fludarabine—DCK—Doxorubicin—Epirubicin—stomach cancer	0.000517	0.162	CbGdCrCtD
Fludarabine—Adenosine triphosphate—PRKAA1—stomach cancer	0.000482	0.0713	CrCbGaD
Fludarabine—DCK—Epirubicin—Doxorubicin—stomach cancer	0.000478	0.15	CbGdCrCtD
Fludarabine—Flavin adenine dinucleotide—DPYD—stomach cancer	0.000474	0.0701	CrCbGaD
Fludarabine—POLA1—E2F transcription factor network—TYMS—stomach cancer	0.000232	0.00237	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP10—stomach cancer	0.000225	0.00231	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—FST—stomach cancer	0.000225	0.00231	CbGpPWpGaD
Fludarabine—POLA1—Synthesis of DNA—APEX1—stomach cancer	0.000224	0.0023	CbGpPWpGaD
Fludarabine—POLA1—Chromosome Maintenance—APEX1—stomach cancer	0.000221	0.00226	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000218	0.00224	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—CDKN1B—stomach cancer	0.000217	0.00222	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CDK4—stomach cancer	0.000214	0.0022	CbGpPWpGaD
Fludarabine—POLA1—DNA Replication—APEX1—stomach cancer	0.00021	0.00215	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—TYMS—stomach cancer	0.000201	0.00206	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—CDKN1A—stomach cancer	0.0002	0.00205	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	0.000197	0.00202	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—RARB—stomach cancer	0.000196	0.00201	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	0.000194	0.00199	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ACAD8—stomach cancer	0.000192	0.00196	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—PLAU—stomach cancer	0.000191	0.00196	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	0.000191	0.00195	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—CDKN1B—stomach cancer	0.000189	0.00193	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—PPP2R1A—stomach cancer	0.000184	0.00189	CbGpPWpGaD
Fludarabine—POLA1—S Phase—APEX1—stomach cancer	0.000184	0.00188	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—CCND1—stomach cancer	0.00018	0.00184	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—CDKN1A—stomach cancer	0.000174	0.00178	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN2D—stomach cancer	0.000174	0.00178	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GMPR2—stomach cancer	0.000171	0.00175	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—IGFBP3—stomach cancer	0.000171	0.00175	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—TYMS—stomach cancer	0.000168	0.00172	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—MYC—stomach cancer	0.000166	0.0017	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000163	0.00167	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CDK4—stomach cancer	0.000157	0.00161	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SUCLG1—stomach cancer	0.000156	0.0016	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—IDH3B—stomach cancer	0.000156	0.0016	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—PPP2R1A—stomach cancer	0.000155	0.00159	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN2D—stomach cancer	0.000155	0.00159	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ANXA1—stomach cancer	0.000153	0.00157	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	0.000149	0.00152	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—SERPINE1—stomach cancer	0.000148	0.00151	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ACAD8—stomach cancer	0.000147	0.00151	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—AURKB—stomach cancer	0.000146	0.00149	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—GADD45A—stomach cancer	0.000146	0.00149	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NDUFV1—stomach cancer	0.000145	0.00149	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NDUFS1—stomach cancer	0.000145	0.00149	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—stomach cancer	0.000145	0.00149	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—stomach cancer	0.000144	0.00148	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—TYMS—stomach cancer	0.000142	0.00145	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	0.00014	0.00143	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—stomach cancer	0.000138	0.00142	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—CDKN2A—stomach cancer	0.000138	0.00141	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1A—stomach cancer	0.000134	0.00137	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CHEK2—stomach cancer	0.000133	0.00136	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GMPR2—stomach cancer	0.000131	0.00135	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	0.00013	0.00133	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PGLS—stomach cancer	0.000129	0.00133	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—BLVRB—stomach cancer	0.000129	0.00133	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PPAP2A—stomach cancer	0.000123	0.00126	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—CDKN1B—stomach cancer	0.000122	0.00125	CbGpPWpGaD
Fludarabine—DCK—Metabolism—IDH3B—stomach cancer	0.00012	0.00123	CbGpPWpGaD
Fludarabine—DCK—Metabolism—SUCLG1—stomach cancer	0.00012	0.00123	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CDK4—stomach cancer	0.000119	0.00122	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—stomach cancer	0.000119	0.00121	CbGpPWpGaD
Fludarabine—SLC28A3—SLC-mediated transmembrane transport—ALB—stomach cancer	0.000116	0.00119	CbGpPWpGaD
Fludarabine—Leukopenia—Docetaxel—stomach cancer	0.000113	0.000673	CcSEcCtD
Fludarabine—Anaemia—Capecitabine—stomach cancer	0.000113	0.000673	CcSEcCtD
Fludarabine—Body temperature increased—Fluorouracil—stomach cancer	0.000113	0.000673	CcSEcCtD
Fludarabine—POLA1—E2F transcription factor network—CDKN1A—stomach cancer	0.000113	0.00116	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NDUFS1—stomach cancer	0.000112	0.00114	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NDUFV1—stomach cancer	0.000112	0.00114	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	0.000111	0.00114	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—stomach cancer	0.000111	0.00114	CbGpPWpGaD
Fludarabine—Haematuria—Methotrexate—stomach cancer	0.000111	0.000662	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDK4—stomach cancer	0.00011	0.00113	CbGpPWpGaD
Fludarabine—Hyperglycaemia—Epirubicin—stomach cancer	0.00011	0.000657	CcSEcCtD
Fludarabine—Malaise—Capecitabine—stomach cancer	0.00011	0.000657	CcSEcCtD
Fludarabine—Cough—Docetaxel—stomach cancer	0.00011	0.000657	CcSEcCtD
Fludarabine—Angina pectoris—Doxorubicin—stomach cancer	0.00011	0.000656	CcSEcCtD
Fludarabine—RRM1—Metabolism—CKB—stomach cancer	0.00011	0.00113	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CA1—stomach cancer	0.00011	0.00113	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—FBP1—stomach cancer	0.00011	0.00113	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NDUFA2—stomach cancer	0.00011	0.00113	CbGpPWpGaD
Fludarabine—Epistaxis—Methotrexate—stomach cancer	0.00011	0.000655	CcSEcCtD
Fludarabine—Hypersensitivity—Irinotecan—stomach cancer	0.00011	0.000654	CcSEcCtD
Fludarabine—Pneumonia—Epirubicin—stomach cancer	0.00011	0.000653	CcSEcCtD
Fludarabine—Leukopenia—Capecitabine—stomach cancer	0.000109	0.000652	CcSEcCtD
Fludarabine—Convulsion—Docetaxel—stomach cancer	0.000109	0.000652	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	0.000109	0.00112	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—AURKB—stomach cancer	0.000109	0.00112	CbGpPWpGaD
Fludarabine—Bronchitis—Doxorubicin—stomach cancer	0.000109	0.000648	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	0.000109	0.00111	CbGpPWpGaD
Fludarabine—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.000108	0.000644	CcSEcCtD
Fludarabine—Myalgia—Docetaxel—stomach cancer	0.000108	0.000641	CcSEcCtD
Fludarabine—Arthralgia—Docetaxel—stomach cancer	0.000108	0.000641	CcSEcCtD
Fludarabine—Pancytopenia—Doxorubicin—stomach cancer	0.000107	0.00064	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	0.000107	0.0011	CbGpPWpGaD
Fludarabine—Renal failure—Epirubicin—stomach cancer	0.000107	0.000638	CcSEcCtD
Fludarabine—Asthenia—Irinotecan—stomach cancer	0.000107	0.000637	CcSEcCtD
Fludarabine—Neuropathy peripheral—Epirubicin—stomach cancer	0.000107	0.000637	CcSEcCtD
Fludarabine—Cough—Capecitabine—stomach cancer	0.000107	0.000636	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—stomach cancer	0.000106	0.00109	CbGpPWpGaD
Fludarabine—Stomatitis—Epirubicin—stomach cancer	0.000106	0.000633	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	0.000106	0.00109	CbGpPWpGaD
Fludarabine—Urinary tract infection—Epirubicin—stomach cancer	0.000106	0.000631	CcSEcCtD
Fludarabine—Neutropenia—Doxorubicin—stomach cancer	0.000106	0.00063	CcSEcCtD
Fludarabine—Dysuria—Doxorubicin—stomach cancer	0.000106	0.00063	CcSEcCtD
Fludarabine—Hypersensitivity—Fluorouracil—stomach cancer	0.000105	0.000627	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000105	0.000626	CcSEcCtD
Fludarabine—Haemoglobin—Methotrexate—stomach cancer	0.000105	0.000626	CcSEcCtD
Fludarabine—Haemorrhage—Methotrexate—stomach cancer	0.000105	0.000623	CcSEcCtD
Fludarabine—Arthralgia—Capecitabine—stomach cancer	0.000104	0.00062	CcSEcCtD
Fludarabine—Myalgia—Capecitabine—stomach cancer	0.000104	0.00062	CcSEcCtD
Fludarabine—Haematuria—Epirubicin—stomach cancer	0.000104	0.000619	CcSEcCtD
Fludarabine—Confusional state—Docetaxel—stomach cancer	0.000104	0.000619	CcSEcCtD
Fludarabine—Pharyngitis—Methotrexate—stomach cancer	0.000104	0.000618	CcSEcCtD
Fludarabine—RRM1—Metabolism—PLIN2—stomach cancer	0.000103	0.00106	CbGpPWpGaD
Fludarabine—Anaphylactic shock—Docetaxel—stomach cancer	0.000103	0.000614	CcSEcCtD
Fludarabine—Oedema—Docetaxel—stomach cancer	0.000103	0.000614	CcSEcCtD
Fludarabine—Discomfort—Capecitabine—stomach cancer	0.000103	0.000613	CcSEcCtD
Fludarabine—Epistaxis—Epirubicin—stomach cancer	0.000103	0.000613	CcSEcCtD
Fludarabine—Infection—Docetaxel—stomach cancer	0.000102	0.00061	CcSEcCtD
Fludarabine—Sinusitis—Epirubicin—stomach cancer	0.000102	0.000609	CcSEcCtD
Fludarabine—Hyperglycaemia—Doxorubicin—stomach cancer	0.000102	0.000608	CcSEcCtD
Fludarabine—Diarrhoea—Irinotecan—stomach cancer	0.000102	0.000608	CcSEcCtD
Fludarabine—Pneumonia—Doxorubicin—stomach cancer	0.000101	0.000604	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—stomach cancer	0.000101	0.00104	CbGpPWpGaD
Fludarabine—Nervous system disorder—Docetaxel—stomach cancer	0.000101	0.000602	CcSEcCtD
Fludarabine—Pruritus—Fluorouracil—stomach cancer	0.000101	0.000602	CcSEcCtD
Fludarabine—Thrombocytopenia—Docetaxel—stomach cancer	0.000101	0.000601	CcSEcCtD
Fludarabine—Visual impairment—Methotrexate—stomach cancer	0.000101	0.0006	CcSEcCtD
Fludarabine—RRM1—Metabolism—CA2—stomach cancer	0.000101	0.00103	CbGpPWpGaD
Fludarabine—Confusional state—Capecitabine—stomach cancer	0.000101	0.000599	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	0.000101	0.00103	CbGpPWpGaD
Fludarabine—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.0001	0.000596	CcSEcCtD
Fludarabine—Oedema—Capecitabine—stomach cancer	9.98e-05	0.000595	CcSEcCtD
Fludarabine—DCK—Metabolism—BLVRB—stomach cancer	9.96e-05	0.00102	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PGLS—stomach cancer	9.96e-05	0.00102	CbGpPWpGaD
Fludarabine—Renal failure—Doxorubicin—stomach cancer	9.91e-05	0.000591	CcSEcCtD
Fludarabine—Infection—Capecitabine—stomach cancer	9.91e-05	0.000591	CcSEcCtD
Fludarabine—Erythema multiforme—Methotrexate—stomach cancer	9.89e-05	0.000589	CcSEcCtD
Fludarabine—Neuropathy peripheral—Doxorubicin—stomach cancer	9.89e-05	0.000589	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—HMOX1—stomach cancer	9.84e-05	0.00101	CbGpPWpGaD
Fludarabine—Haemoglobin—Epirubicin—stomach cancer	9.83e-05	0.000586	CcSEcCtD
Fludarabine—Stomatitis—Doxorubicin—stomach cancer	9.83e-05	0.000586	CcSEcCtD
Fludarabine—Anorexia—Docetaxel—stomach cancer	9.82e-05	0.000585	CcSEcCtD
Fludarabine—POLA1—Synthesis of DNA—CDKN1B—stomach cancer	9.82e-05	0.00101	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PGAM1—stomach cancer	9.81e-05	0.001	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NT5E—stomach cancer	9.81e-05	0.001	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1A—stomach cancer	9.81e-05	0.001	CbGpPWpGaD
Fludarabine—Urinary tract infection—Doxorubicin—stomach cancer	9.8e-05	0.000584	CcSEcCtD
Fludarabine—Nervous system disorder—Capecitabine—stomach cancer	9.78e-05	0.000583	CcSEcCtD
Fludarabine—Haemorrhage—Epirubicin—stomach cancer	9.78e-05	0.000583	CcSEcCtD
Fludarabine—Diarrhoea—Fluorouracil—stomach cancer	9.77e-05	0.000582	CcSEcCtD
Fludarabine—Thrombocytopenia—Capecitabine—stomach cancer	9.77e-05	0.000582	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—AURKB—stomach cancer	9.75e-05	0.000998	CbGpPWpGaD
Fludarabine—Hypoaesthesia—Epirubicin—stomach cancer	9.73e-05	0.00058	CcSEcCtD
Fludarabine—Pharyngitis—Epirubicin—stomach cancer	9.71e-05	0.000579	CcSEcCtD
Fludarabine—Hyperhidrosis—Capecitabine—stomach cancer	9.65e-05	0.000575	CcSEcCtD
Fludarabine—Haematuria—Doxorubicin—stomach cancer	9.62e-05	0.000573	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	9.59e-05	0.000983	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	9.57e-05	0.000981	CbGpPWpGaD
Fludarabine—Epistaxis—Doxorubicin—stomach cancer	9.51e-05	0.000567	CcSEcCtD
Fludarabine—Anorexia—Capecitabine—stomach cancer	9.51e-05	0.000567	CcSEcCtD
Fludarabine—DCK—Metabolism—PPAP2A—stomach cancer	9.5e-05	0.000973	CbGpPWpGaD
Fludarabine—Vomiting—Irinotecan—stomach cancer	9.48e-05	0.000565	CcSEcCtD
Fludarabine—Sinusitis—Doxorubicin—stomach cancer	9.46e-05	0.000564	CcSEcCtD
Fludarabine—Visual impairment—Epirubicin—stomach cancer	9.43e-05	0.000562	CcSEcCtD
Fludarabine—Rash—Irinotecan—stomach cancer	9.4e-05	0.00056	CcSEcCtD
Fludarabine—Dermatitis—Irinotecan—stomach cancer	9.39e-05	0.00056	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Docetaxel—stomach cancer	9.39e-05	0.000559	CcSEcCtD
Fludarabine—Chills—Methotrexate—stomach cancer	9.38e-05	0.000559	CcSEcCtD
Fludarabine—RRM1—Metabolism—PLCE1—stomach cancer	9.36e-05	0.000959	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ALDH7A1—stomach cancer	9.36e-05	0.000959	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—MYC—stomach cancer	9.36e-05	0.000958	CbGpPWpGaD
Fludarabine—Headache—Irinotecan—stomach cancer	9.34e-05	0.000556	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	9.28e-05	0.000951	CbGpPWpGaD
Fludarabine—Paraesthesia—Docetaxel—stomach cancer	9.25e-05	0.000551	CcSEcCtD
Fludarabine—Erythema multiforme—Epirubicin—stomach cancer	9.25e-05	0.000551	CcSEcCtD
Fludarabine—Alopecia—Methotrexate—stomach cancer	9.24e-05	0.00055	CcSEcCtD
Fludarabine—POLA1—DNA Replication—CDKN1B—stomach cancer	9.21e-05	0.000944	CbGpPWpGaD
Fludarabine—Dyspnoea—Docetaxel—stomach cancer	9.19e-05	0.000547	CcSEcCtD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—stomach cancer	9.12e-05	0.000935	CbGpPWpGaD
Fludarabine—Malnutrition—Methotrexate—stomach cancer	9.1e-05	0.000542	CcSEcCtD
Fludarabine—Haemoglobin—Doxorubicin—stomach cancer	9.1e-05	0.000542	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Capecitabine—stomach cancer	9.09e-05	0.000542	CcSEcCtD
Fludarabine—Vomiting—Fluorouracil—stomach cancer	9.08e-05	0.000541	CcSEcCtD
Fludarabine—Dyspepsia—Docetaxel—stomach cancer	9.07e-05	0.000541	CcSEcCtD
Fludarabine—POLA1—Synthesis of DNA—CDKN1A—stomach cancer	9.06e-05	0.000928	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	9.06e-05	0.000928	CbGpPWpGaD
Fludarabine—Haemorrhage—Doxorubicin—stomach cancer	9.05e-05	0.000539	CcSEcCtD
Fludarabine—Hypoaesthesia—Doxorubicin—stomach cancer	9.01e-05	0.000537	CcSEcCtD
Fludarabine—Rash—Fluorouracil—stomach cancer	9e-05	0.000536	CcSEcCtD
Fludarabine—Dermatitis—Fluorouracil—stomach cancer	8.99e-05	0.000536	CcSEcCtD
Fludarabine—Pharyngitis—Doxorubicin—stomach cancer	8.98e-05	0.000535	CcSEcCtD
Fludarabine—RRM1—Metabolism—UMPS—stomach cancer	8.97e-05	0.000919	CbGpPWpGaD
Fludarabine—Paraesthesia—Capecitabine—stomach cancer	8.96e-05	0.000534	CcSEcCtD
Fludarabine—Decreased appetite—Docetaxel—stomach cancer	8.96e-05	0.000534	CcSEcCtD
Fludarabine—Headache—Fluorouracil—stomach cancer	8.94e-05	0.000533	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Docetaxel—stomach cancer	8.9e-05	0.00053	CcSEcCtD
Fludarabine—Dyspnoea—Capecitabine—stomach cancer	8.9e-05	0.00053	CcSEcCtD
Fludarabine—Fatigue—Docetaxel—stomach cancer	8.88e-05	0.000529	CcSEcCtD
Fludarabine—POLA1—G1/S Transition—CDKN1B—stomach cancer	8.87e-05	0.000909	CbGpPWpGaD
Fludarabine—Nausea—Irinotecan—stomach cancer	8.86e-05	0.000528	CcSEcCtD
Fludarabine—Constipation—Docetaxel—stomach cancer	8.81e-05	0.000525	CcSEcCtD
Fludarabine—Pain—Docetaxel—stomach cancer	8.81e-05	0.000525	CcSEcCtD
Fludarabine—Dyspepsia—Capecitabine—stomach cancer	8.78e-05	0.000523	CcSEcCtD
Fludarabine—Chills—Epirubicin—stomach cancer	8.78e-05	0.000523	CcSEcCtD
Fludarabine—Arrhythmia—Epirubicin—stomach cancer	8.74e-05	0.000521	CcSEcCtD
Fludarabine—Visual impairment—Doxorubicin—stomach cancer	8.72e-05	0.00052	CcSEcCtD
Fludarabine—Decreased appetite—Capecitabine—stomach cancer	8.67e-05	0.000517	CcSEcCtD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—ALB—stomach cancer	8.67e-05	0.000888	CbGpPWpGaD
Fludarabine—Alopecia—Epirubicin—stomach cancer	8.65e-05	0.000515	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Capecitabine—stomach cancer	8.61e-05	0.000513	CcSEcCtD
Fludarabine—Fatigue—Capecitabine—stomach cancer	8.6e-05	0.000513	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—NPM1—stomach cancer	8.58e-05	0.000879	CbGpPWpGaD
Fludarabine—Erythema multiforme—Doxorubicin—stomach cancer	8.56e-05	0.00051	CcSEcCtD
Fludarabine—Pain—Capecitabine—stomach cancer	8.53e-05	0.000508	CcSEcCtD
Fludarabine—Constipation—Capecitabine—stomach cancer	8.53e-05	0.000508	CcSEcCtD
Fludarabine—Malnutrition—Epirubicin—stomach cancer	8.52e-05	0.000507	CcSEcCtD
Fludarabine—POLA1—DNA Replication—CDKN1A—stomach cancer	8.5e-05	0.000871	CbGpPWpGaD
Fludarabine—Feeling abnormal—Docetaxel—stomach cancer	8.49e-05	0.000506	CcSEcCtD
Fludarabine—Nausea—Fluorouracil—stomach cancer	8.48e-05	0.000505	CcSEcCtD
Fludarabine—DCK—Metabolism—CA1—stomach cancer	8.47e-05	0.000868	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CKB—stomach cancer	8.47e-05	0.000868	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NDUFA2—stomach cancer	8.47e-05	0.000868	CbGpPWpGaD
Fludarabine—DCK—Metabolism—FBP1—stomach cancer	8.47e-05	0.000868	CbGpPWpGaD
Fludarabine—Ill-defined disorder—Methotrexate—stomach cancer	8.44e-05	0.000503	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—stomach cancer	8.44e-05	0.000865	CbGpPWpGaD
Fludarabine—Anaemia—Methotrexate—stomach cancer	8.41e-05	0.000501	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	8.37e-05	0.000857	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	8.36e-05	0.000857	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PDHA1—stomach cancer	8.34e-05	0.000854	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ECHS1—stomach cancer	8.34e-05	0.000854	CbGpPWpGaD
Fludarabine—Feeling abnormal—Capecitabine—stomach cancer	8.22e-05	0.00049	CcSEcCtD
Fludarabine—Malaise—Methotrexate—stomach cancer	8.21e-05	0.000489	CcSEcCtD
Fludarabine—POLA1—G1/S Transition—CDKN1A—stomach cancer	8.19e-05	0.000839	CbGpPWpGaD
Fludarabine—Body temperature increased—Docetaxel—stomach cancer	8.15e-05	0.000485	CcSEcCtD
Fludarabine—Leukopenia—Methotrexate—stomach cancer	8.15e-05	0.000485	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—stomach cancer	8.13e-05	0.000833	CbGpPWpGaD
Fludarabine—Chills—Doxorubicin—stomach cancer	8.12e-05	0.000484	CcSEcCtD
Fludarabine—Arrhythmia—Doxorubicin—stomach cancer	8.09e-05	0.000482	CcSEcCtD
Fludarabine—POLA1—S Phase—CDKN1B—stomach cancer	8.05e-05	0.000825	CbGpPWpGaD
Fludarabine—Alopecia—Doxorubicin—stomach cancer	8e-05	0.000477	CcSEcCtD
Fludarabine—DCK—Metabolism—PLIN2—stomach cancer	7.96e-05	0.000816	CbGpPWpGaD
Fludarabine—Cough—Methotrexate—stomach cancer	7.94e-05	0.000473	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	7.91e-05	0.000811	CbGpPWpGaD
Fludarabine—Ill-defined disorder—Epirubicin—stomach cancer	7.9e-05	0.000471	CcSEcCtD
Fludarabine—Body temperature increased—Capecitabine—stomach cancer	7.89e-05	0.00047	CcSEcCtD
Fludarabine—Convulsion—Methotrexate—stomach cancer	7.89e-05	0.00047	CcSEcCtD
Fludarabine—Malnutrition—Doxorubicin—stomach cancer	7.88e-05	0.00047	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	7.88e-05	0.000807	CbGpPWpGaD
Fludarabine—Anaemia—Epirubicin—stomach cancer	7.87e-05	0.000469	CcSEcCtD
Fludarabine—RRM1—Metabolism—TYMP—stomach cancer	7.84e-05	0.000803	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—FADS1—stomach cancer	7.84e-05	0.000803	CbGpPWpGaD
Fludarabine—Agitation—Epirubicin—stomach cancer	7.83e-05	0.000466	CcSEcCtD
Fludarabine—Arthralgia—Methotrexate—stomach cancer	7.75e-05	0.000462	CcSEcCtD
Fludarabine—Myalgia—Methotrexate—stomach cancer	7.75e-05	0.000462	CcSEcCtD
Fludarabine—DCK—Metabolism—CA2—stomach cancer	7.75e-05	0.000793	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	7.7e-05	0.000788	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CCND1—stomach cancer	7.68e-05	0.000787	CbGpPWpGaD
Fludarabine—Malaise—Epirubicin—stomach cancer	7.68e-05	0.000458	CcSEcCtD
Fludarabine—Discomfort—Methotrexate—stomach cancer	7.66e-05	0.000456	CcSEcCtD
Fludarabine—Leukopenia—Epirubicin—stomach cancer	7.62e-05	0.000454	CcSEcCtD
Fludarabine—POLA1—Mitotic M-M/G1 phases—PPP2R1A—stomach cancer	7.62e-05	0.00078	CbGpPWpGaD
Fludarabine—Hypersensitivity—Docetaxel—stomach cancer	7.59e-05	0.000452	CcSEcCtD
Fludarabine—DCK—Metabolism—PGAM1—stomach cancer	7.55e-05	0.000773	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NT5E—stomach cancer	7.55e-05	0.000773	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	7.53e-05	0.000771	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	7.53e-05	0.000771	CbGpPWpGaD
Fludarabine—Confusional state—Methotrexate—stomach cancer	7.49e-05	0.000446	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—stomach cancer	7.48e-05	0.000766	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—APOA1—stomach cancer	7.46e-05	0.000764	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CDKN1A—stomach cancer	7.43e-05	0.000761	CbGpPWpGaD
Fludarabine—Cough—Epirubicin—stomach cancer	7.43e-05	0.000443	CcSEcCtD
Fludarabine—Anaphylactic shock—Methotrexate—stomach cancer	7.43e-05	0.000443	CcSEcCtD
Fludarabine—Asthenia—Docetaxel—stomach cancer	7.39e-05	0.000441	CcSEcCtD
Fludarabine—Convulsion—Epirubicin—stomach cancer	7.38e-05	0.00044	CcSEcCtD
Fludarabine—Infection—Methotrexate—stomach cancer	7.38e-05	0.00044	CcSEcCtD
Fludarabine—Hypersensitivity—Capecitabine—stomach cancer	7.35e-05	0.000438	CcSEcCtD
Fludarabine—RRM1—Metabolism—SREBF2—stomach cancer	7.34e-05	0.000752	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—HMOX1—stomach cancer	7.34e-05	0.000752	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	7.34e-05	0.000752	CbGpPWpGaD
Fludarabine—Ill-defined disorder—Doxorubicin—stomach cancer	7.31e-05	0.000436	CcSEcCtD
Fludarabine—Pruritus—Docetaxel—stomach cancer	7.29e-05	0.000434	CcSEcCtD
Fludarabine—Nervous system disorder—Methotrexate—stomach cancer	7.28e-05	0.000434	CcSEcCtD
Fludarabine—Anaemia—Doxorubicin—stomach cancer	7.28e-05	0.000434	CcSEcCtD
Fludarabine—Thrombocytopenia—Methotrexate—stomach cancer	7.27e-05	0.000433	CcSEcCtD
Fludarabine—RRM1—Metabolism—RORA—stomach cancer	7.26e-05	0.000743	CbGpPWpGaD
Fludarabine—Myalgia—Epirubicin—stomach cancer	7.25e-05	0.000432	CcSEcCtD
Fludarabine—Arthralgia—Epirubicin—stomach cancer	7.25e-05	0.000432	CcSEcCtD
Fludarabine—Agitation—Doxorubicin—stomach cancer	7.24e-05	0.000432	CcSEcCtD
Fludarabine—DCK—Metabolism—PLCE1—stomach cancer	7.2e-05	0.000738	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ALDH7A1—stomach cancer	7.2e-05	0.000738	CbGpPWpGaD
Fludarabine—Hyperhidrosis—Methotrexate—stomach cancer	7.18e-05	0.000428	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	7.17e-05	0.000734	CbGpPWpGaD
Fludarabine—Discomfort—Epirubicin—stomach cancer	7.16e-05	0.000427	CcSEcCtD
Fludarabine—Asthenia—Capecitabine—stomach cancer	7.16e-05	0.000427	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CCND1—stomach cancer	7.13e-05	0.000731	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	7.11e-05	0.000728	CbGpPWpGaD
Fludarabine—Malaise—Doxorubicin—stomach cancer	7.11e-05	0.000423	CcSEcCtD
Fludarabine—Anorexia—Methotrexate—stomach cancer	7.08e-05	0.000422	CcSEcCtD
Fludarabine—Pruritus—Capecitabine—stomach cancer	7.06e-05	0.000421	CcSEcCtD
Fludarabine—Leukopenia—Doxorubicin—stomach cancer	7.05e-05	0.00042	CcSEcCtD
Fludarabine—Diarrhoea—Docetaxel—stomach cancer	7.05e-05	0.00042	CcSEcCtD
Fludarabine—Confusional state—Epirubicin—stomach cancer	7.01e-05	0.000418	CcSEcCtD
Fludarabine—Anaphylactic shock—Epirubicin—stomach cancer	6.95e-05	0.000414	CcSEcCtD
Fludarabine—Oedema—Epirubicin—stomach cancer	6.95e-05	0.000414	CcSEcCtD
Fludarabine—Infection—Epirubicin—stomach cancer	6.91e-05	0.000411	CcSEcCtD
Fludarabine—DCK—Metabolism—UMPS—stomach cancer	6.9e-05	0.000707	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN1A—stomach cancer	6.9e-05	0.000707	CbGpPWpGaD
Fludarabine—Cough—Doxorubicin—stomach cancer	6.88e-05	0.00041	CcSEcCtD
Fludarabine—Convulsion—Doxorubicin—stomach cancer	6.83e-05	0.000407	CcSEcCtD
Fludarabine—Diarrhoea—Capecitabine—stomach cancer	6.83e-05	0.000407	CcSEcCtD
Fludarabine—Nervous system disorder—Epirubicin—stomach cancer	6.82e-05	0.000406	CcSEcCtD
Fludarabine—Thrombocytopenia—Epirubicin—stomach cancer	6.81e-05	0.000406	CcSEcCtD
Fludarabine—RRM1—Metabolism—ALDOB—stomach cancer	6.8e-05	0.000697	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—MYC—stomach cancer	6.79e-05	0.000695	CbGpPWpGaD
Fludarabine—Musculoskeletal discomfort—Methotrexate—stomach cancer	6.77e-05	0.000403	CcSEcCtD
Fludarabine—Hyperhidrosis—Epirubicin—stomach cancer	6.72e-05	0.0004	CcSEcCtD
Fludarabine—Arthralgia—Doxorubicin—stomach cancer	6.71e-05	0.0004	CcSEcCtD
Fludarabine—Myalgia—Doxorubicin—stomach cancer	6.71e-05	0.0004	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—stomach cancer	6.68e-05	0.000684	CbGpPWpGaD
Fludarabine—Paraesthesia—Methotrexate—stomach cancer	6.67e-05	0.000397	CcSEcCtD
Fludarabine—Discomfort—Doxorubicin—stomach cancer	6.63e-05	0.000395	CcSEcCtD
Fludarabine—Anorexia—Epirubicin—stomach cancer	6.63e-05	0.000395	CcSEcCtD
Fludarabine—Dyspnoea—Methotrexate—stomach cancer	6.62e-05	0.000395	CcSEcCtD
Fludarabine—Vomiting—Docetaxel—stomach cancer	6.55e-05	0.00039	CcSEcCtD
Fludarabine—Dyspepsia—Methotrexate—stomach cancer	6.54e-05	0.00039	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	6.53e-05	0.000669	CbGpPWpGaD
Fludarabine—Rash—Docetaxel—stomach cancer	6.5e-05	0.000387	CcSEcCtD
Fludarabine—Dermatitis—Docetaxel—stomach cancer	6.49e-05	0.000387	CcSEcCtD
Fludarabine—Confusional state—Doxorubicin—stomach cancer	6.49e-05	0.000386	CcSEcCtD
Fludarabine—Decreased appetite—Methotrexate—stomach cancer	6.46e-05	0.000385	CcSEcCtD
Fludarabine—Headache—Docetaxel—stomach cancer	6.46e-05	0.000385	CcSEcCtD
Fludarabine—Anaphylactic shock—Doxorubicin—stomach cancer	6.43e-05	0.000383	CcSEcCtD
Fludarabine—Oedema—Doxorubicin—stomach cancer	6.43e-05	0.000383	CcSEcCtD
Fludarabine—DCK—Metabolism—PDHA1—stomach cancer	6.42e-05	0.000657	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ECHS1—stomach cancer	6.42e-05	0.000657	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Methotrexate—stomach cancer	6.41e-05	0.000382	CcSEcCtD
Fludarabine—Fatigue—Methotrexate—stomach cancer	6.4e-05	0.000382	CcSEcCtD
Fludarabine—Infection—Doxorubicin—stomach cancer	6.39e-05	0.000381	CcSEcCtD
Fludarabine—Pain—Methotrexate—stomach cancer	6.35e-05	0.000378	CcSEcCtD
Fludarabine—Vomiting—Capecitabine—stomach cancer	6.34e-05	0.000378	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Epirubicin—stomach cancer	6.33e-05	0.000377	CcSEcCtD
Fludarabine—RRM1—Metabolism—ALOX5—stomach cancer	6.32e-05	0.000648	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	6.32e-05	0.000647	CbGpPWpGaD
Fludarabine—Nervous system disorder—Doxorubicin—stomach cancer	6.31e-05	0.000376	CcSEcCtD
Fludarabine—Thrombocytopenia—Doxorubicin—stomach cancer	6.3e-05	0.000375	CcSEcCtD
Fludarabine—Rash—Capecitabine—stomach cancer	6.29e-05	0.000375	CcSEcCtD
Fludarabine—Dermatitis—Capecitabine—stomach cancer	6.29e-05	0.000375	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—APEX1—stomach cancer	6.26e-05	0.000641	CbGpPWpGaD
Fludarabine—Headache—Capecitabine—stomach cancer	6.25e-05	0.000372	CcSEcCtD
Fludarabine—POLA1—Mitotic M-M/G1 phases—BIRC5—stomach cancer	6.25e-05	0.00064	CbGpPWpGaD
Fludarabine—Paraesthesia—Epirubicin—stomach cancer	6.24e-05	0.000372	CcSEcCtD
Fludarabine—RRM1—Metabolism—DPYD—stomach cancer	6.22e-05	0.000637	CbGpPWpGaD
Fludarabine—Hyperhidrosis—Doxorubicin—stomach cancer	6.22e-05	0.00037	CcSEcCtD
Fludarabine—Dyspnoea—Epirubicin—stomach cancer	6.2e-05	0.000369	CcSEcCtD
Fludarabine—POLA1—S Phase—MYC—stomach cancer	6.16e-05	0.000631	CbGpPWpGaD
Fludarabine—Anorexia—Doxorubicin—stomach cancer	6.13e-05	0.000365	CcSEcCtD
Fludarabine—Nausea—Docetaxel—stomach cancer	6.12e-05	0.000365	CcSEcCtD
Fludarabine—Feeling abnormal—Methotrexate—stomach cancer	6.12e-05	0.000365	CcSEcCtD
Fludarabine—Dyspepsia—Epirubicin—stomach cancer	6.12e-05	0.000365	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	6.12e-05	0.000627	CbGpPWpGaD
Fludarabine—Decreased appetite—Epirubicin—stomach cancer	6.04e-05	0.00036	CcSEcCtD
Fludarabine—DCK—Metabolism—FADS1—stomach cancer	6.03e-05	0.000618	CbGpPWpGaD
Fludarabine—DCK—Metabolism—TYMP—stomach cancer	6.03e-05	0.000618	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Epirubicin—stomach cancer	6e-05	0.000358	CcSEcCtD
Fludarabine—Fatigue—Epirubicin—stomach cancer	5.99e-05	0.000357	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	5.98e-05	0.000613	CbGpPWpGaD
Fludarabine—Constipation—Epirubicin—stomach cancer	5.94e-05	0.000354	CcSEcCtD
Fludarabine—Pain—Epirubicin—stomach cancer	5.94e-05	0.000354	CcSEcCtD
Fludarabine—Nausea—Capecitabine—stomach cancer	5.93e-05	0.000353	CcSEcCtD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—ALB—stomach cancer	5.91e-05	0.000606	CbGpPWpGaD
Fludarabine—Body temperature increased—Methotrexate—stomach cancer	5.87e-05	0.00035	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	5.86e-05	0.000349	CcSEcCtD
Fludarabine—Paraesthesia—Doxorubicin—stomach cancer	5.78e-05	0.000344	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—CHEK2—stomach cancer	5.76e-05	0.00059	CbGpPWpGaD
Fludarabine—Dyspnoea—Doxorubicin—stomach cancer	5.73e-05	0.000342	CcSEcCtD
Fludarabine—Feeling abnormal—Epirubicin—stomach cancer	5.73e-05	0.000341	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—MYC—stomach cancer	5.72e-05	0.000586	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—PPP2R1A—stomach cancer	5.7e-05	0.000584	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	5.66e-05	0.00058	CbGpPWpGaD
Fludarabine—Dyspepsia—Doxorubicin—stomach cancer	5.66e-05	0.000337	CcSEcCtD
Fludarabine—DCK—Metabolism—SREBF2—stomach cancer	5.65e-05	0.000579	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—APEX1—stomach cancer	5.6e-05	0.000573	CbGpPWpGaD
Fludarabine—Decreased appetite—Doxorubicin—stomach cancer	5.59e-05	0.000333	CcSEcCtD
Fludarabine—DCK—Metabolism—RORA—stomach cancer	5.58e-05	0.000572	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—APOA1—stomach cancer	5.56e-05	0.00057	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Doxorubicin—stomach cancer	5.55e-05	0.000331	CcSEcCtD
Fludarabine—Fatigue—Doxorubicin—stomach cancer	5.55e-05	0.00033	CcSEcCtD
Fludarabine—Constipation—Doxorubicin—stomach cancer	5.5e-05	0.000328	CcSEcCtD
Fludarabine—Pain—Doxorubicin—stomach cancer	5.5e-05	0.000328	CcSEcCtD
Fludarabine—RRM1—Metabolism—GSTT1—stomach cancer	5.5e-05	0.000563	CbGpPWpGaD
Fludarabine—Body temperature increased—Epirubicin—stomach cancer	5.49e-05	0.000327	CcSEcCtD
Fludarabine—Hypersensitivity—Methotrexate—stomach cancer	5.47e-05	0.000326	CcSEcCtD
Fludarabine—RRM1—Metabolism—CYP2A6—stomach cancer	5.44e-05	0.000557	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	5.4e-05	0.000554	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	5.39e-05	0.000552	CbGpPWpGaD
Fludarabine—Asthenia—Methotrexate—stomach cancer	5.33e-05	0.000318	CcSEcCtD
Fludarabine—POLA1—Mitotic M-M/G1 phases—PRKCB—stomach cancer	5.33e-05	0.000546	CbGpPWpGaD
Fludarabine—Feeling abnormal—Doxorubicin—stomach cancer	5.3e-05	0.000316	CcSEcCtD
Fludarabine—RRM1—Metabolism—AKR1C3—stomach cancer	5.29e-05	0.000542	CbGpPWpGaD
Fludarabine—Pruritus—Methotrexate—stomach cancer	5.26e-05	0.000313	CcSEcCtD
Fludarabine—DCK—Metabolism—ALDOB—stomach cancer	5.23e-05	0.000536	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	5.23e-05	0.000536	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—TYMS—stomach cancer	5.2e-05	0.000532	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ENO1—stomach cancer	5.15e-05	0.000528	CbGpPWpGaD
Fludarabine—Hypersensitivity—Epirubicin—stomach cancer	5.12e-05	0.000305	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	5.1e-05	0.000523	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—PPP2R1A—stomach cancer	5.09e-05	0.000522	CbGpPWpGaD
Fludarabine—Body temperature increased—Doxorubicin—stomach cancer	5.08e-05	0.000303	CcSEcCtD
Fludarabine—Diarrhoea—Methotrexate—stomach cancer	5.08e-05	0.000303	CcSEcCtD
Fludarabine—Asthenia—Epirubicin—stomach cancer	4.99e-05	0.000297	CcSEcCtD
Fludarabine—Pruritus—Epirubicin—stomach cancer	4.92e-05	0.000293	CcSEcCtD
Fludarabine—DCK—Metabolism—ALOX5—stomach cancer	4.86e-05	0.000498	CbGpPWpGaD
Fludarabine—DCK—Metabolism—DPYD—stomach cancer	4.79e-05	0.00049	CbGpPWpGaD
Fludarabine—Diarrhoea—Epirubicin—stomach cancer	4.76e-05	0.000283	CcSEcCtD
Fludarabine—Hypersensitivity—Doxorubicin—stomach cancer	4.74e-05	0.000282	CcSEcCtD
Fludarabine—Vomiting—Methotrexate—stomach cancer	4.72e-05	0.000281	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	4.71e-05	0.000483	CbGpPWpGaD
Fludarabine—Rash—Methotrexate—stomach cancer	4.68e-05	0.000279	CcSEcCtD
Fludarabine—Dermatitis—Methotrexate—stomach cancer	4.68e-05	0.000279	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—BIRC5—stomach cancer	4.67e-05	0.000479	CbGpPWpGaD
Fludarabine—Headache—Methotrexate—stomach cancer	4.65e-05	0.000277	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—TYMS—stomach cancer	4.65e-05	0.000476	CbGpPWpGaD
Fludarabine—Asthenia—Doxorubicin—stomach cancer	4.61e-05	0.000275	CcSEcCtD
Fludarabine—RRM1—Metabolism—CD44—stomach cancer	4.57e-05	0.000468	CbGpPWpGaD
Fludarabine—Pruritus—Doxorubicin—stomach cancer	4.55e-05	0.000271	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	4.46e-05	0.000457	CbGpPWpGaD
Fludarabine—Vomiting—Epirubicin—stomach cancer	4.42e-05	0.000263	CcSEcCtD
Fludarabine—Nausea—Methotrexate—stomach cancer	4.41e-05	0.000263	CcSEcCtD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—ALB—stomach cancer	4.41e-05	0.000451	CbGpPWpGaD
Fludarabine—Diarrhoea—Doxorubicin—stomach cancer	4.4e-05	0.000262	CcSEcCtD
Fludarabine—Rash—Epirubicin—stomach cancer	4.38e-05	0.000261	CcSEcCtD
Fludarabine—Dermatitis—Epirubicin—stomach cancer	4.38e-05	0.000261	CcSEcCtD
Fludarabine—Headache—Epirubicin—stomach cancer	4.35e-05	0.000259	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	4.33e-05	0.000444	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	4.24e-05	0.000434	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	4.24e-05	0.000434	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTT1—stomach cancer	4.23e-05	0.000433	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CYP2A6—stomach cancer	4.18e-05	0.000428	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—BIRC5—stomach cancer	4.18e-05	0.000428	CbGpPWpGaD
Fludarabine—Nausea—Epirubicin—stomach cancer	4.13e-05	0.000246	CcSEcCtD
Fludarabine—Vomiting—Doxorubicin—stomach cancer	4.09e-05	0.000244	CcSEcCtD
Fludarabine—DCK—Metabolism—AKR1C3—stomach cancer	4.07e-05	0.000417	CbGpPWpGaD
Fludarabine—Rash—Doxorubicin—stomach cancer	4.06e-05	0.000242	CcSEcCtD
Fludarabine—Dermatitis—Doxorubicin—stomach cancer	4.05e-05	0.000241	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDK4—stomach cancer	4.05e-05	0.000415	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	4.04e-05	0.000414	CbGpPWpGaD
Fludarabine—Headache—Doxorubicin—stomach cancer	4.03e-05	0.00024	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	4e-05	0.00041	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—PRKCB—stomach cancer	3.98e-05	0.000408	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ENO1—stomach cancer	3.97e-05	0.000406	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PPP2R1A—stomach cancer	3.89e-05	0.000398	CbGpPWpGaD
Fludarabine—Nausea—Doxorubicin—stomach cancer	3.82e-05	0.000228	CcSEcCtD
Fludarabine—RRM1—Metabolism—GSTP1—stomach cancer	3.81e-05	0.00039	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—HMOX1—stomach cancer	3.76e-05	0.000385	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	3.68e-05	0.000377	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDK4—stomach cancer	3.62e-05	0.000371	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—PRKCB—stomach cancer	3.56e-05	0.000365	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	3.56e-05	0.000365	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—TYMS—stomach cancer	3.54e-05	0.000363	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CD44—stomach cancer	3.52e-05	0.00036	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—GSTM1—stomach cancer	3.5e-05	0.000359	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ERCC2—stomach cancer	3.29e-05	0.000337	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—stomach cancer	3.1e-05	0.000317	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—MTHFR—stomach cancer	3.1e-05	0.000317	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PPP2R1A—stomach cancer	2.99e-05	0.000306	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTP1—stomach cancer	2.93e-05	0.0003	CbGpPWpGaD
Fludarabine—DCK—Metabolism—HMOX1—stomach cancer	2.89e-05	0.000296	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—MAPK3—stomach cancer	2.88e-05	0.000295	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—CAV1—stomach cancer	2.86e-05	0.000292	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—APOA1—stomach cancer	2.85e-05	0.000292	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN2A—stomach cancer	2.77e-05	0.000284	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—MAPK1—stomach cancer	2.74e-05	0.000281	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN1B—stomach cancer	2.74e-05	0.000281	CbGpPWpGaD
Fludarabine—DCK—Metabolism—TYMS—stomach cancer	2.73e-05	0.000279	CbGpPWpGaD
Fludarabine—DCK—Metabolism—GSTM1—stomach cancer	2.7e-05	0.000276	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CCND1—stomach cancer	2.62e-05	0.000268	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ERCC2—stomach cancer	2.53e-05	0.00026	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN1A—stomach cancer	2.53e-05	0.000259	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PPARG—stomach cancer	2.51e-05	0.000257	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN1B—stomach cancer	2.45e-05	0.000251	CbGpPWpGaD
Fludarabine—DCK—Metabolism—MTHFR—stomach cancer	2.38e-05	0.000244	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CCND1—stomach cancer	2.34e-05	0.00024	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CDKN1A—stomach cancer	2.26e-05	0.000232	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—ALB—stomach cancer	2.26e-05	0.000231	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CAV1—stomach cancer	2.2e-05	0.000225	CbGpPWpGaD
Fludarabine—DCK—Metabolism—APOA1—stomach cancer	2.19e-05	0.000225	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—NOS3—stomach cancer	2.16e-05	0.000221	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MAPK3—stomach cancer	2.16e-05	0.000221	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MYC—stomach cancer	2.1e-05	0.000215	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MAPK1—stomach cancer	2.05e-05	0.00021	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PTGS2—stomach cancer	1.97e-05	0.000202	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PPARG—stomach cancer	1.93e-05	0.000198	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MAPK3—stomach cancer	1.93e-05	0.000198	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MYC—stomach cancer	1.88e-05	0.000192	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MAPK1—stomach cancer	1.84e-05	0.000188	CbGpPWpGaD
Fludarabine—DCK—Metabolism—ALB—stomach cancer	1.74e-05	0.000178	CbGpPWpGaD
Fludarabine—DCK—Metabolism—NOS3—stomach cancer	1.66e-05	0.00017	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—TP53—stomach cancer	1.54e-05	0.000158	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PTGS2—stomach cancer	1.52e-05	0.000156	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CA—stomach cancer	1.21e-05	0.000124	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CA—stomach cancer	9.35e-06	9.58e-05	CbGpPWpGaD
